“A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR”, Journal of Pharmaceutical Negative Results, pp. 217–225, Nov. 2022, doi: 10.47750/pnr.2022.13.S09.026.